Vera Dermics, Inc announced it raised $22.2 Million in an initial filing from an offering of $22.2 Million

Company

Location

About

Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company focused on turning everyday dermatology and aesthetics problems into clear, proven care. We are on a mission to make long-ignored dermatology and aesthetics conditions simple, replacing false hope, confusion, and questionable results with solutions that people and providers can trust. Our lead investigational product has the potential to be the first non-hormonal oral therapeutic for hair regrowth in women and men. Pattern hair loss, also known as androgenetic alopecia, is the largest aesthetics condition worldwide, with no new approved prescription therapies in nearly 30 years.